Literature DB >> 8306158

Patterns of bone metastasis and their prognostic significance in patients with carcinoma of the prostate.

A Rana1, G D Chisholm, M Khan, S S Sekharjit, M V Merrick, R A Elton.   

Abstract

The different patterns of bone metastasis, metastatic load and their prognostic significance were examined in a consecutive series of 169 men with prostatic cancer and bone metastasis at presentation. Patients with an isolated metastasis in the pelvis or dorsal vertebrae had a better prognosis than those whose metastases were either diffuse or involved more distal sites such as the skull or the sternum, although all of these patients were classified as having M1 disease. Bone metastasis involving an area equivalent to 1 vertebral body equalled a metastatic load of 2. Based on their total metastatic load, 3 prognostic groups were identified with significant differences in case-specific survival despite receiving the same hormonal treatment. When comparing the potential efficacy of various treatments one must stratify the metastatic load, which is a powerful prognostic indicator of the outcome in patients with metastatic carcinoma of the prostate.

Entities:  

Mesh:

Year:  1993        PMID: 8306158     DOI: 10.1111/j.1464-410x.1993.tb16301.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  18 in total

1.  Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis.

Authors:  K Kuchta; Y Xiang; S Huang; Y Tang; X Peng; X Wang; Y Zhu; J Li; J Xu; Z Lin; T Pan
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-02-14       Impact factor: 5.554

2.  Predictive value of the clinically and scintigraphically important bone lesions in hormone-refractory prostate cancer (HRPC).

Authors:  Athanasios Zafeirakis; Georgios S Limouris
Journal:  Clin Transl Oncol       Date:  2009-11       Impact factor: 3.405

3.  Cranial nerve deficit caused by skull metastasis of prostate cancer: three Japanese castration-resistant prostate cancer cases.

Authors:  Kouji Izumi; Atsushi Mizokami; Kazutaka Narimoto; Kazuhiro Sugimoto; Eitetsu Koh; Tomoyasu Kumano; Mikio Namiki
Journal:  Int J Clin Oncol       Date:  2010-06-05       Impact factor: 3.402

4.  1,25-Dihydroxyvitamin D(3) regulates PTHrP expression via transcriptional, post-transcriptional and post-translational pathways.

Authors:  Vandanajay Bhatia; Ramanjaneya V Mula; Miriam Falzon
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

5.  Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.

Authors:  Daniel W Lin; Liesel M FitzGerald; Rong Fu; Erika M Kwon; Siqun Lilly Zheng; Suzanne Kolb; Fredrik Wiklund; Pär Stattin; William B Isaacs; Jianfeng Xu; Elaine A Ostrander; Ziding Feng; Henrik Grönberg; Janet L Stanford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-08-16       Impact factor: 4.254

6.  Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.

Authors:  Yi Lu; Jian Zhang; Jinlu Dai; Lindsay A Dehne; Atsushi Mizokami; Zhi Yao; Evan T Keller
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

7.  Osteoblast-derived factors induce an expression signature that identifies prostate cancer metastasis and hormonal progression.

Authors:  Gang Wang; Simon Haile; Barbara Comuzzi; Amy H Tien; Jun Wang; Theresa M K Yong; Anca E Jelescu-Bodos; Natalie Blaszczyk; Robert L Vessella; Bassam A Masri; Marianne D Sadar
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

8.  Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment.

Authors:  Younghun Jung; Yusuke Shiozawa; Jingcheng Wang; Natalie McGregor; Jinlu Dai; Serk In Park; Janice E Berry; Aaron M Havens; Jeena Joseph; Jin Koo Kim; Lalit Patel; Peter Carmeliet; Stephanie Daignault; Evan T Keller; Laurie K McCauley; Kenneth J Pienta; Russell S Taichman
Journal:  Neoplasia       Date:  2012-05       Impact factor: 5.715

9.  Electroacupuncture attenuates bone-cancer-induced hyperalgesia and inhibits spinal preprodynorphin expression in a rat model.

Authors:  Rui-Xin Zhang; Aihui Li; Bing Liu; Linbo Wang; Jiajia Xin; Ke Ren; Jian-Tian Qiao; Brian M Berman; Lixing Lao
Journal:  Eur J Pain       Date:  2008-01-24       Impact factor: 3.931

10.  EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.

Authors:  Vandanajay Bhatia; Manjit K Saini; Xiaoli Shen; Lian X Bi; Suimin Qiu; Nancy L Weigel; Miriam Falzon
Journal:  Mol Cancer Ther       Date:  2009-07-07       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.